Literature DB >> 8206130

Full and partial agonistic behaviour and thermodynamic binding parameters of adenosine A1 receptor ligands.

P A Borea1, K Varani, A Dalpiaz, A Capuzzo, E Fabbri, A P IJzerman.   

Abstract

The inhibitory effect of forskolin-stimulated 3',5'-cyclic monophosphate (c-AMP) synthesis in isolated rat adipocytes has been measured for eight typical adenosine receptor agonists. The percent inhibition was evaluated using concentrations of each compound corresponding to 100 times their Ki, inhibitory binding constants, determined in parallel by [3H]N6-cyclohexyladenosine binding to adenosine A1 receptors on adipocyte rat membranes which guaranteed full receptor occupancy. Some drugs were able to inhibit the forskolin-induced c-AMP accumulation by 100% (full agonists, intrinsic activity = 1) but others only to a lesser extent, ranging from 80% to 50% (partial agonists, intrinsic activities in the 0.8-0.5 interval). These efficacy data were correlated with the thermodynamic binding parameters (free energy, enthalpy and entropy) obtained in rat brain membranes by equilibrium constant measurements and van 't Hoff plots in the 0 degrees-30 degrees C range. The positive correlation between intrinsic activity and entropy changes (r = 0.88, n = 8, P < 0.01) points to the possibility of obtaining information about the full spectrum of activities of adenosine analogues from in vitro binding assays and suggests some considerations on the possible drug-receptor interaction mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206130     DOI: 10.1016/0922-4106(94)90224-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Thermodynamically distinct high and low affinity states of the A(1) adenosine receptor induced by G protein coupling and guanine nucleotide ligation states of G proteins.

Authors:  A Lorenzen; L Guerra; F Campi; H Lang; U Schwabe; P A Borea
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

Authors:  K Varani; F Vincenzi; A Tosi; M Targa; F F Masieri; A Ongaro; M De Mattei; L Massari; P A Borea
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

3.  Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A1 receptor ligands.

Authors:  A Dalpiaz; A Scatturin; B Pavan; K Varani; A P IJzerman; P Andrea Borea
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

4.  Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

Authors:  Laura H Heitman; Thea Mulder-Krieger; Ronald F Spanjersberg; Jacobien K von Frijtag Drabbe Künzel; Alessandro Dalpiaz; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

5.  Adenosine signaling contributes to ethanol-induced fatty liver in mice.

Authors:  Zhongsheng Peng; Pier Andrea Borea; Katia Varani; Tuere Wilder; Herman Yee; Luis Chiriboga; Michael R Blackburn; Gianfranco Azzena; Giuseppe Resta; Bruce N Cronstein
Journal:  J Clin Invest       Date:  2009-02-16       Impact factor: 14.808

6.  The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43.

Authors:  Ikuo Kimura; Kentaro Ozawa; Daisuke Inoue; Takeshi Imamura; Kumi Kimura; Takeshi Maeda; Kazuya Terasawa; Daiji Kashihara; Kanako Hirano; Taeko Tani; Tomoyuki Takahashi; Satoshi Miyauchi; Go Shioi; Hiroshi Inoue; Gozoh Tsujimoto
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.